1. Noninvasive assessment of fetal central nervous system insult: Potential application to prenatal diagnosis
- Author
-
Laura Goetzl, Nune Darbinian, and Nana Merabova
- Subjects
0301 basic medicine ,Fetus ,030219 obstetrics & reproductive medicine ,biology ,business.industry ,Central nervous system ,Obstetrics and Gynecology ,Prenatal diagnosis ,030105 genetics & heredity ,Exosome ,Andrology ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Placenta ,Synaptophysin ,biology.protein ,Medicine ,Synaptopodin ,Neurogranin ,business ,Genetics (clinical) - Abstract
OBJECTIVE We have developed novel methods for isolating fetal central nervous system (CNS)-derived extracellular vesicles (FCEs) from maternal plasma as a non-invasive platform for testing aspects of fetal neurodevelopment in early pregnancy. We investigate the hypothesis that levels of defined sets of functional proteins in FCEs can be used to detect abnormalities in fetal neuronal and glial proliferation, differentiation, and survival. METHOD Maternal plasma was obtained between 10 and 19 weeks from women with current heavy EtOH exposure and matched controls. FCE levels of synaptophysin, synaptotagmin, synaptopodin, and neurogranin were quantified normalized to the exosome marker CD81. Quantitative RT-PCR was performed with specific primers for miR-9. RESULTS FCE cargo protein levels of synaptophysin, synaptotagmin, synaptopodin, and neurogranin were all significantly reduced in pregnancies exposed to current heavy EtOH use (P
- Published
- 2019